Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of PDR
Public ClinicalTrials.gov record NCT06790784. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized Clinical Trial Evaluating Combination Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of Proliferative Diabetic Retinopathy
Study identification
- NCT ID
- NCT06790784
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Jaeb Center for Health Research
- Other
- Enrollment
- 426 participants
Conditions and interventions
Conditions
Interventions
- Endolaser Device
- Faricimab Drug
- Panretinal Photocoagulation (PRP) Device
- Vitrectomy Procedure
Device · Drug · Procedure
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 3, 2025
- Primary completion
- Jul 31, 2031
- Completion
- Jul 31, 2031
- Last update posted
- Jan 28, 2026
2025 – 2031
United States locations
- U.S. sites
- 20
- U.S. states
- 15
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Retina Associates of Southern California | Huntington Beach | California | 92647 | Recruiting |
| Loma Linda University | Loma Linda | California | 92354 | Recruiting |
| Florida Retina Consultants | Lakeland | Florida | 33805 | Recruiting |
| Ophthalmic Partners of Florida, PA dba Central Florida Retina | Orlando | Florida | 32806 | Recruiting |
| Retina Associates of Florida, LLC | Tampa | Florida | 33609 | Recruiting |
| Southeast Retina Center, P.C. | Augusta | Georgia | 30909 | Recruiting |
| Illinois Retina Associates SC Oak Park Site | Oak Park | Illinois | 60304 | Recruiting |
| Midwest Eye Institute | Carmel | Indiana | 46032 | Recruiting |
| Wolfe Clinic, P.C.- West Des Moines | West Des Moines | Iowa | 50266 | Recruiting |
| Mid-America Retina Consultants, P.A. | Overland | Kansas | 66211 | Recruiting |
| University of Kentucky Advanced Eye Care | Lexington | Kentucky | 40508 | Recruiting |
| Elman Retina Group, P.A. | Baltimore | Maryland | 21237 | Recruiting |
| Boston Medical Center Corporation | Boston | Massachusetts | 02118 | Recruiting |
| Joslin Diabetes Center | Boston | Massachusetts | 02215 | Recruiting |
| Mayo Clinic | Rochester | Minnesota | 55905 | Recruiting |
| Retina Research Institute, LLC | St Louis | Missouri | 63128 | Recruiting |
| Retina Associates of Western NY, P.C. | Rochester | New York | 14620 | Recruiting |
| Retina-Vitreous Consultants, Inc. | Monroeville | Pennsylvania | 15146 | Recruiting |
| Retina Consultants of Texas, PA | Bellaire | Texas | 77401 | Recruiting |
| Texas Retina Associates | Lubbock | Texas | 79424 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06790784, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 28, 2026 · Synced May 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06790784 live on ClinicalTrials.gov.